OTUB1 and plasma cell myeloma: A screen for bioactive inhibitors of the Otub1/c-Maf axis in multiple myeloma cells demonstrated that NCMC induces c-Maf polyubiquitination and proteasomal degradation in the presence of Otub1 (Xu et al., 2020).